Consistently, Singh et al. 31 also reported that C-reactive protein, a cardiovascular risk marker leading to endothelial dysfunction, causes decreased eNOS activity and NO production by downregulating eNOS phosphorylation in ECs without changing the total eNOS abundance. This evidence concerns the gene NOS3 and endothelial dysfunction.